Shikoku Kasei Holdings recorded record-high consolidated revenue of ¥45.841 billion and operating profit of ¥9.439 billion for the interim period of the fiscal year ending December 2026. The company raised its full-year outlook after consolidating Timuraya from the second quarter.
Shikoku Kasei Holdings outlined its results for the interim period of the fiscal year ending December 2026, reporting revenue of ¥45.841 billion, operating profit of ¥9.439 billion and ordinary profit of ¥9.692 billion. Increased sales in the Chemicals business, led by Fine Chemicals, resulted in record highs for revenue and profits at every level. Regarding foreign exchange effects, the profit-and-loss statement conversion rate was ¥158 to the US dollar, contributing approximately ¥1.26 billion to revenue and ¥860 million to operating profit. ROE was 13.6% at the end of the second quarter, up 4.8 percentage points year on year.
The Chemicals business, which comprises the three segments Inorganic Chemicals, Organic Chemicals and Fine Chemicals, recorded higher revenue. Inorganic Chemicals in particular benefited from soaring sulfur prices. The consolidation of Timuraya contributed approximately ¥2.5 billion to the increase in revenue in the Inorganic Chemicals segment, while Organic Chemicals also performed steadily, supported by North American sales of chlorine-based disinfectants. Fine Chemicals performed well in both the Functional Materials and Electronic Chemicals fields, with demand for GliCAP showing particularly notable growth. In the Construction Materials business, wall materials contributed to higher revenue, while the Exterior business recorded lower revenue due to delays in construction schedules and other factors.
The full-year forecast for the fiscal year ending December 2026 was revised to reflect the impact of consolidating Timuraya. Consolidated revenue is projected at ¥94.0 billion, operating profit at ¥18.0 billion, ordinary profit at ¥18.4 billion and net profit at ¥12.6 billion. Capital expenditure for the interim period totaled ¥15.27 billion, with investments at the Sakaide Plant, those related to the Tokushima Plant and a new building at the R&D Center accounting for the largest amounts. The annual dividend is expected to be ¥40, resulting in a projected payout ratio of 27.5%. The company indicated that it aims to raise ROE and improve capital efficiency while maintaining financial soundness.
These are the key facts.